76 related articles for article (PubMed ID: 12657200)
1. Interleukin-2 enhances susceptibility of colon cancer cells to FasR mediated apoptosis by up-regulating Fas receptor level and down-regulating FAP-1 expression.
Song E; Chen J; Antus B; Wang M; Xie Y; Yao H; Exton MS
Int J Immunopathol Pharmacol; 2000; 13(3):113-122. PubMed ID: 12657200
[TBL] [Abstract][Full Text] [Related]
2. Cytokine associated sensitivity of colon carcinoma cells to FasR-mediated cytotoxicity of CTL.
Chen J; Zhang H; Su F; Min J; Zhang J; Song E
Asian J Surg; 2002 Jan; 25(1):89-97. PubMed ID: 17585452
[TBL] [Abstract][Full Text] [Related]
3. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.
Yao H; Song E; Chen J; Hamar P
Br J Cancer; 2004 Nov; 91(9):1718-25. PubMed ID: 15494722
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of Fas-associated phosphatase-1 (FAP-1) in interleukin-2-activated T cells.
Zhou YW; Komada Y; Inaba H; Azuma E; Sakurai M
Cell Immunol; 1998 Jun; 186(2):103-10. PubMed ID: 9665752
[TBL] [Abstract][Full Text] [Related]
5. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
O'Connell J; O'Sullivan GC; Collins JK; Shanahan F
J Exp Med; 1996 Sep; 184(3):1075-82. PubMed ID: 9064324
[TBL] [Abstract][Full Text] [Related]
6. Conversion of Fas-resistant to Fas-sensitive MCF-7 breast cancer cells by the synergistic interaction of interferon-gamma and all-trans retinoic acid.
Danforth DN; Zhu Y
Breast Cancer Res Treat; 2005 Nov; 94(1):81-91. PubMed ID: 16136269
[TBL] [Abstract][Full Text] [Related]
7. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
[TBL] [Abstract][Full Text] [Related]
8. Fas-associated phosphatase-1 promotes Fas-mediated apoptosis in human colon cancer cells: novel function of FAP-1.
Miyazaki T; Atarashi Y; Yasumura S; Minatoya I; Ogawa K; Iwamoto M; Minemura M; Shimizu Y; Sato TA; Watanabe A; Sugiyama T
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):84-91. PubMed ID: 16706817
[TBL] [Abstract][Full Text] [Related]
9. Kupffer cells of cirrhotic rat livers sensitize colon cancer cells to Fas-mediated apoptosis.
Song E; Chen J; Ouyang N; Wang M; Exton MS; Heemann U
Br J Cancer; 2001 May; 84(9):1265-71. PubMed ID: 11336480
[TBL] [Abstract][Full Text] [Related]
10. FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis.
Wieckowski E; Atarashi Y; Stanson J; Sato TA; Whiteside TL
J Cell Biochem; 2007 Jan; 100(1):16-28. PubMed ID: 16888780
[TBL] [Abstract][Full Text] [Related]
11. Postexposure application of Fas receptor small-interfering RNA to suppress sulfur mustard-induced apoptosis in human airway epithelial cells: implication for a therapeutic approach.
Keyser BM; Andres DK; Nealley E; Holmes WW; Benton B; Paradiso D; Appell A; Carpin C; Anderson DR; Smith WJ; Ray R
J Pharmacol Exp Ther; 2013 Jan; 344(1):308-16. PubMed ID: 23129783
[TBL] [Abstract][Full Text] [Related]
12. Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor.
Tucek-Szabo CL; Andjelić S; Lacy E; Elkon KB; Nikolić-Zugić J
J Immunol; 1996 Jan; 156(1):192-200. PubMed ID: 8598462
[TBL] [Abstract][Full Text] [Related]
13. Expression and function of the murine CD95/FasR/APO-1 receptor in relation to B cell ontogeny.
Onel KB; Tucek-Szabo CL; Ashany D; Lacy E; Nikolic-Zugic J; Elkon KB
Eur J Immunol; 1995 Oct; 25(10):2940-7. PubMed ID: 7589095
[TBL] [Abstract][Full Text] [Related]
14. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.
O'Connell J; Bennett MW; O'Sullivan GC; Roche D; Kelly J; Collins JK; Shanahan F
J Pathol; 1998 Nov; 186(3):240-6. PubMed ID: 10211111
[TBL] [Abstract][Full Text] [Related]
15. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
[TBL] [Abstract][Full Text] [Related]
16. Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells.
Zhu Q; Liu JY; Yang CM; Xu HW; Zhang AZ; Cui Y; Wang HB; Qin CY; Li YQ
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1071-7. PubMed ID: 16957513
[TBL] [Abstract][Full Text] [Related]
17. Fas (APO-1, CD95) receptor expression and new options for immunotherapy in childhood medulloblastomas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1999; 19(4B):3293-314. PubMed ID: 10652626
[TBL] [Abstract][Full Text] [Related]
18. Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients.
Arai M; Kannagi M; Matsuoka M; Sato T; Yamamoto N; Fujii M
AIDS Res Hum Retroviruses; 1998 Feb; 14(3):261-7. PubMed ID: 9491917
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation-Based signaling in Fas receptor-mediated apoptosis.
Holmström TH; Eriksson JE
Crit Rev Immunol; 2000; 20(2):121-52. PubMed ID: 10872894
[TBL] [Abstract][Full Text] [Related]
20. Fas-mediated apoptosis and expression of related genes in human malignant hematopoietic cells.
Kim KM; Lee K; Hong YS; Park HY
Exp Mol Med; 2000 Dec; 32(4):246-54. PubMed ID: 11190279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
